4//SEC Filing
SPECTRUM PHARMACEUTICALS INC 4
Accession 0001209191-17-040199
CIK 0000831547operating
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 5:12 PM ET
Size
9.2 KB
Accession
0001209191-17-040199
Insider Transaction Report
Form 4
Vyas Dolatrai
Director
Transactions
- Award
Common Stock, $0.001 par value
2017-06-13+10,000→ 37,871 total - Tax Payment
Common Stock, $0.001 par value
2017-06-13$6.48/sh−3,170$20,542→ 27,871 total - Award
Common Stock (Right to Buy)
2017-06-13+20,000→ 20,000 totalExercise: $6.48Exp: 2027-06-13→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]Represents shares withheld by Spectrum to satisfy the Reporting Person's tax withholding obligations. The shares have not been sold by the Reporting Person or by Spectrum. The shares have been cancelled by the transfer agent.
- [F2]100% of the restricted shares shall vest on the earlier of (1) June 13, 2018 or (2) the date of the company's 2018 Annual Meeting of Shareholders.
- [F3]25% of the option shares vested on June 13, 2017. The remaining option shares shall vest in 25% equal annual amounts on each anniversary date of the grant over three years.
Documents
Issuer
SPECTRUM PHARMACEUTICALS INC
CIK 0000831547
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000831547
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 5:12 PM ET
- Size
- 9.2 KB